ESMO discussants urge physicians to prescribe lower dose of Amgen’s sotorasib Experts in pharmacology and lung cancer urged physicians to prescribe the Amgen agent Lumakras (sotorasib) at the lowest tested dose—240 mg—instead of the four times higher dose of 960 mg recommended by the sponsor.November 17, 2023Vol.49 No.43By Paul Goldberg